NASDAQ
Cardiff Oncology, Inc. (CRDF) reported revenue of $593.00K and net income of $-45,851,000 for FY 2025, with a net profit margin of -7732.0%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.